14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $30.23 $38.44 Friday, 3rd May 2024 TARS stock ended at $36.85. This is 6.41% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.59% from a day low at $35.51 to a day high of $37.14.
90 days $27.45 $40.40
52 weeks $12.66 $40.40

Historical Tarsus Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $35.75 $37.14 $35.51 $36.85 652 217
May 02, 2024 $32.31 $34.63 $32.02 $34.63 439 520
May 01, 2024 $31.36 $33.49 $30.71 $32.49 712 016
Apr 30, 2024 $31.51 $32.00 $30.23 $31.43 445 798
Apr 29, 2024 $32.31 $33.19 $31.83 $32.12 418 035
Apr 26, 2024 $32.57 $33.21 $31.26 $32.04 366 893
Apr 25, 2024 $31.85 $32.62 $31.49 $32.21 321 409
Apr 24, 2024 $33.98 $34.35 $32.41 $32.76 308 040
Apr 23, 2024 $32.14 $34.11 $32.14 $33.71 211 725
Apr 22, 2024 $33.04 $33.25 $31.88 $32.29 274 590
Apr 19, 2024 $32.44 $33.69 $31.75 $32.44 622 546
Apr 18, 2024 $33.97 $34.55 $32.81 $32.85 317 820
Apr 17, 2024 $35.11 $35.11 $33.91 $34.42 271 584
Apr 16, 2024 $34.50 $36.57 $34.42 $34.90 396 351
Apr 15, 2024 $36.25 $36.73 $34.75 $34.94 322 363
Apr 12, 2024 $38.23 $38.34 $35.02 $36.17 388 353
Apr 11, 2024 $35.89 $38.44 $35.55 $38.29 841 533
Apr 10, 2024 $35.31 $36.48 $35.12 $35.88 429 748
Apr 09, 2024 $35.60 $36.52 $34.67 $36.26 474 413
Apr 08, 2024 $35.03 $35.55 $34.48 $35.21 230 642
Apr 05, 2024 $34.76 $35.34 $34.33 $34.74 235 159
Apr 04, 2024 $36.48 $36.70 $34.77 $34.94 354 351
Apr 03, 2024 $35.22 $36.11 $34.99 $35.88 435 601
Apr 02, 2024 $35.05 $36.11 $34.90 $35.58 441 647
Apr 01, 2024 $36.54 $37.35 $35.49 $35.85 757 054
Click to get the best stock tips daily for free!

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals. Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; a... TARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT